期刊文献+

米诺环素在皮肤科临床中的应用 被引量:10

Clinical application of minocycline in dermatology
下载PDF
导出
摘要 米诺环素为半合成的四环素类抗生素,属于第二代四环素类抗生素,具有高效性和长效性,在四环素类抗生素中,抗菌作用最强。除了抗微生物作用,还有多种生物作用,如抗炎、抗凋亡、抑制蛋白水解,以及抑制血管生成和肿瘤转移等作用。临床上,四环素已被用于治疗各种皮肤疾病,如痤疮、酒渣鼻、大疱性皮肤病等。该文综述了米诺环素治疗皮肤病的新的进展,如治疗白癜风、色素性痒疹、自身免疫性大疱病、肉芽肿性疾病等,以期为一些皮肤病的治疗有药物禁忌时提供辅助或备选方法。 Minocycline is a second-generation, semi-synthetic tetracycline that has the strongest antibacterial effect in the tetracycline. In addition to anti-microbial effect, tetracyclines can exert a variety of biological actions that are independent of their anti-microbial activity, including anti-infl ammatory and anti-apoptotic activities, inhibition of proteolysis, inhibition of angiogenesis and tumor metastasis and so on. Clinically, tetracycline has been used to treat various skin diseases such as acne, rosacea, bullous skin diseases. This paper reviews new developments of the minocycline in the treatment of dermatosis, such as the treatment of vitiligo, prurigo pigmentosa, et al, so as to provide a reference for the treatment of some skin diseases by using minocycline.
机构地区 南京中医药大学
出处 《实用皮肤病学杂志》 2016年第2期120-123,共4页 Journal of Practical Dermatology
关键词 米诺环素 皮肤病 临床应用 Minocycline Skin diseases Clinical application
  • 相关文献

参考文献29

  • 1Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications [J]. J Am Acad Dermatol, 2006, 54(2):258-265.
  • 2Ishikawa C, Tsuda T, Konishi H, et al. Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinoeytes [J]. Antimicrob Agents Chemother, 2009, 53(5):1760-1765.
  • 3Griffin MO, Frieovsky E, Ceballos G, et al. Tetracyelines: a pleitropie family of compounds with promising therapeutic properties. Review of the literature [J]. Am J Physiol Cell Physiol, 2010, 299(3): C539-548.
  • 4Dalm D, Palm GJ, Aleksandrov A, et al. Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2 [J]. J Mol Biol, 2010, 398(1):83-96.
  • 5Leite LM, Carvalho AG, Ferreira PL, et al. Anti-inflammatory properties of doxycycline and minoeyeline in experimental models: an in vivo and in vilxo comparative study [J]. Inflammopharrnacology,2011, 19(2):99-110.
  • 6Tomts-Camardiel M1, Rite I, Herrera AJ, et al. Minocycline reduces the lipopolysaeeharide-induced inflammatory reaction, peroxynitrite- mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system [J]. Neurobiol Dis, 2004, 16(1):190-201.
  • 7Ocampo-Candiani J, Velazquez-Arenas LL, de la Fuente-Garcia A, et al. Safety and efficacy comparison of minocycline microgranules vs lymecycline in the treatment of mild to moderate acne:randomized, evaluator-blinded, parallel, and prospective clinical trial for 8 weeks [J]. J Drugs Dermatol, 2014, 13(6):671-676.
  • 8Yamada M, Iihara H, Fujii H, et al. Prophylactic effect of oral minocycline in combination with topical steroid and skin care against panitumumab-induced acneiform rash in metastatic colorectal cancer patients [J]. Anticancer Res, 2015, 35(11):6175-6181.
  • 9Yang F, Zhou L, Wang D, et al. Minocycline ameliorates hypoxia- induced blood-brain barrier damage by inhibition ofHIF-1 a through SIRT-3/PHD-2 degradation pathway [J]. Neuroscience, 2015, 304:250-259.
  • 10van Zuuren E J, Fedorowicz Z. Interventions for rosacea [J]. JAMA. 2015, 314(22):2403-2404.

同被引文献100

引证文献10

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部